The Cannabis Conversation Podcast

This week, we’re joined by Karan Wadhera, Founder and Managing Partner at Casa Verde Capital, US based venture capital fund focusing exclusively on the cannabis industry. 

In this episode we learn how the VC fund is helping to support and develop ancillary businesses, alongside serving the diverse needs of the cannabis industry. Karan also gives us an overview of the cannabis investment landscape in the USA, including what VCs are looking for and investor types.

→ View full show notes, summary, and access resources here:

https://www.canverse.global/shownotes/e122

About Karan Wadhera

Casa Verde Capital is the premier venture capital firm in the cannabis industry. Karan is the firm’s Managing Partner responsible for investment strategy, fundraising, and portfolio anagement. He provides leadership and guidance as a Director on the board of 10 cannabis companies.

During his tenure at Casa Verde, Karan has been responsible for raising & deploying over $150mm across his vehicle & co-invests in over 20 portfolio companies, which have collectively raised more than $500mm in funding. As an established thought leader in the space, Mr. Wadhera has been featured in numerous mainstream press outlets and conferences, including the Milken Global Conference, Wall Street Journal, Barrons,  CNBC, Bloomberg, TechCrunch, Financial Times, and more.

Prior to Casa Verde, Mr. Wadhera held senior roles at Goldman Sachs and Nomura in domestic and international markets such as New York, San Francisco, Hong Kong, and Mumbai. While in India, Karan was part of the founding team of Goldman’s India Equities business. Furthermore, Karan is an active private investor and advisor to a number of young companies around the world; he co-founded MissMalini.com, one of India's most well-known digital media and entertainment brands. Similarly, Karan was an early investor in Steadview, which is now the world’s largest India dedicated hedge fund. Karan is a Boston native and received his BA from Babson College.

Resources

Join Karan Wadhera on LinkedIn: https://www.linkedin.com/in/karan-wadhera/

Follow Casa Verde Capital on LinkedIn: https://www.linkedin.com/company/casa-verde-capital/

Casa Verde Capital’s Website: https://www.casaverdecapital.com/

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

How Do You Fit Cannabis Into Western Medicine?

This week, we’re joined by Dr. Ruth Fisher, economist, Co-Founder of CannDynamics and author of The Medical Cannabis Primer.

In this show, we explore the market drivers behind the western medical system and its commoditisation of pharmaceuticals, alongside some of the difficulties and complexities faced integrating medical cannabis into the rigid international healthcare system.

→ View full show notes, summary, and access resources here: 

https://www.canverse.global/shownotes/e121

About Dr. Ruth Fisher

Dr. Ruth Fisher, PhD, has 25 years of experience in the technology and healthcare industries, analyzing information for most participants in the healthcare system. She has experience with patient health and behavior; drug company research, sales, and patterns of use; healthcare provider (hospitals, clinics, outpatient centers, physician offices) expenses, processes, billing, and patient information; and insurance company patient premiums and provider reimbursements. She has worked on behalf of biotech companies, early-stage biotech researchers, physicians, and healthcare technology start-ups.

Dr. Fisher came to cannabis in 2015 to help her brother figure out how to use medical cannabis to address his MS-induced neuropathic pain. Since she found cannabis, she has become an ardent researcher and advocate for medical cannabis use. As an economist, she’s also fascinated by cannabis technologies and market dynamics – how the industry is evolving in medical and recreational use, and how well the industry is serving market participants.

Dr. Fisher and her brother, Art Fisher have published The Medical Cannabis Primer: Ushering in the golden Age of Marijuana, and they have an online certificate course, Medical Cannabis Fundamentals.

Dr. Fisher is also author of Winning the Hardware-Software Game: Using Game Theory to Optimize the Pace of New Technology Adoption.  She holds a B.A. in Mathematics from the University of Pennsylvania and a Ph.D. in Economics from the University of Chicago.

Resources

Join Dr. Ruth Fisher on LinkedIn: https://www.linkedin.com/in/rfisher/

Follow CannDynamic on LinkedIn: https://www.linkedin.com/company/canndynamics/about/

CannDynamics Website: https://canndynamics.com/

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

What is Cannabinoid Hyperemesis Syndrome (CHS)?

This week, we welcome back Dr. Ethan Russo, physician, researcher, and leading expert in the field of Medicinal Cannabis. 

In this episode, Dr Russo shares the latest research and findings of the largest study on CHS to date - in which his team identified 6 potential genetic targets to assist in the diagnosis and treatment of the condition.

→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e120

About Dr. Ethan Russo

Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com 

Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®.

He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles.

Resources

Join Dr. Russo on LinkedIn: https://www.linkedin.com/in/ethan-russo-md-468b19a/

View Dr. Russo’s clinical research papers: https://www.researchgate.net/profile/Ethan_Russo

CReDO Science Website: https://credo-science.com/

Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation Paper: https://pubmed.ncbi.nlm.nih.gov/34227878/

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

This week, we’re joined by Dr. Stephen Barnhill (CEO) & Rod Mcllree (Investor and Advisor) from Apollon Formularies, medical cannabis company based in Jamaica.

We investigate Dr. Barnhill’s pioneering research into the use of medical cannabis for cancer, Jamaica’s medical trial and licensing rules, and the influence of the Rastafari on the evolving domestic industry.

→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e119

About Dr. Stephen Barnhill

Dr. Stephen Barnhill is a medical doctor with 35 years’ experience as Chairman and CEO of numerous publicly traded and private companies specializing in laboratory medicine, biotechnology, and pharmaceuticals. He was an early pioneer in the use of artificial intelligence (machine learning) techniques in medicine, primarily in the field of cancer diagnostics. 

Dr. Barnhill is an inventor on more than 40 international patents on artificial intelligence and his patents were part of the Intellectual Property portfolio that won MDB Capital’s MICO Award for most disruptive IP portfolio out of 1,600 publicly traded companies. Some of Dr. Barnhill’s early AI patents were acquired by Johnson and Johnson.

About Rod Mcllree

Roderick McIllree is a London based high net worth investor and shareholder in Apollon formularies Plc. He advised and assisted Dr Barnhill and his team on the public listing of the company in April 2021. 

Resources

Join Dr. Barnhill on LinkedIn: https://www.linkedin.com/in/stephenbarnhill/?originalSubdomain=uk

Follow Apollon Formularies on LinkedIn: https://www.linkedin.com/company/apollon-formularies/

Visit Apollon Formularies’ Website: https://www.apollon.org.uk/

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

This week, we welcome back to the show Dr. Markus Roggen, President and CSO of Delic Labs (formerly Complex Biotech Discovery Ventures) - licensed cannabis and psilocybin research laboratory in Vancouver.

We explore the function and potential therapeutic uses of psilocybin, the similarities between the cannabis and mushroom industries, and how Delic Labs is driving R+D within the emerging mushroom industry.

→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e118

About Dr. Roggen

Dr. Markus Roggen is President and Chief Scientific Officer of Delic Labs, a licensed cannabis and psilocybin research laboratory focused on extraction optimization, analytical testing, and process development. Delic Labs is one of a handful of research labs licensed for both cannabis and psilocybin in Canada. Delic Labs was initially founded as Complex Biotech Discovery Ventures by Dr. Roggen and Prof. Dr. Glenn Sammis in 2018, and rebranded after the sale to Delic Corp. 

Dr. Roggen received his M/Sci degree from Imperial College, London, UK in 2008. He then pursued his graduate degree in organic chemistry at the Federal Institute of Technology in Zürich (ETHZ), where he received his PhD in 2012. Dr. Roggen was awarded an DAAD postdoctoral fellowship to pursue further training in physical organic chemistry at The Scripps Research Institute in La Jolla in 2013-2014. He then entered the cannabis industry in 2014 and since has held executive positions in analytical and production companies. His research into process optimization and analytical methods has been recognized with a number of awards, ElSohley Award of the ACS, Cannabis Scientist Power List 2020 & 2021, 40 under 40 by Marijuana Venture Magazine among others. Dr. Roggen is also a trusted advisor and mentor to multiple startups, startup accelerators and organizations.

 Quotables

The psychedelic mushroom industry is very much in its infancy 15:08

Resources

Join Dr. Roggen on LinkedIn: https://www.linkedin.com/in/markus-roggen-13a9b286/

Visit Delic Labs Website: https://deliclabs.com/

Follow Complex Biotech Discovery Ventures on LinkedIn: https://www.linkedin.com/company/cbdvl/

Follow Complex Biotech Discovery Ventures on Instagram: https://www.instagram.com/complexbiotech/

Listen to our last episode with Dr. Roggen: https://podcasts.apple.com/us/podcast/episode-89-chemistry-cannabis-dr-markus-roggen-ceo/id1454098889?i=1000500068104

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

This week, we welcome back Aurélien Bernard and Benjamin-Alexandre Jeanroy, Co-Founders of Augur Associates - French cannabis consultancy based in Paris.

In this episode, our guests update us on the current regulations and restrictions of cannabis production and use in France, we also discuss France’s new medical cannabis trial, and how the country’s traditionally conservative opinions towards cannabis are changing for the better.

→ View full show notes, summary, and access resources here: https://www.canverse.global/shownotes/e117

About Aurélien

Former web project manager for Webedia, Aurelien is the founder of Newsweed, the reference media in France for the past 6 years on legal and global cannabis news. His expertise ranges from in-depth theoretical to a technical and practical field market vision of the cannabis & hemp industries and ecosystems in France, at the EU and global level, as well as of the plant itself. He has collaborated with some of the largest European and North-American companies and has the most developed network in France on the medical cannabis and wellness hemp value chains.

About Benjamin-Alexandre

Former consultant for the United Nations Office on Drugs and Crime (UNODC), Benjamin-Alexandre co-founded in 2016 the think tank ECHO Citoyen working on drug policy reform in France. He is also the co-founder of the Syndicat Professionnel du Chanvre (SPC), of the european and french chapters of LEAP, of the Thémis participatory network, of the French Psychedelic Society, and of the patient advocacy group Espoir (Im)patient. For the past 5 years in France, he has worked towards creating bridges between actors involved around cannabis, notably through his work with the French Professional Hemp Union (Syndicat Professionnel du Chanvre - SPC) and the production of its collaborative groundbreaking white papers.

Quotables

There is a strong need and demand for knowledge from health practitioners… who are interested in getting to know more about this complex topic 29:50

Resources

Join Benjamin-Alexandre on LinkedIn: https://www.linkedin.com/in/benjaminalexandrejeanroy/

Join Aurélien on LinkedIn:  https://www.linkedin.com/in/aurelienbernard/

Augur Associates LinkedIn: https://www.linkedin.com/company/augur-associates/

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

This week, we’re joined by Matt Clifton, CEO of Product Earth and founder of Marketing Agency, Milk & Amber.

In this episode, we explore the biggest marketing and advertising challenges within the cannabis space, the importance of brand building, and how to target cannabis consumers.

→ View full show notes, summary, and access resources here: 

https://www.canverse.global/shownotes/e116

About Matt

With 22 years of sales and marketing experience, spanning a variety of media disciplines, Matt was fortunate to have been one of the original international employees at Facebook, where he spent 12 years honing his unique skill set. Having headed up Facebook product marketing for SMBs across EMEA, Matt built an affinity for not only growing businesses, but also working at scale.

By bringing together this knowledge with his passion for cannabis and his commitment to a customer first approach, he looks forward to helping companies navigate the complex and highly regulated world of cannabis marketing and beyond.

Quotables

This isn’t a narcotic in the sense that you should be running for the hills, this is a drug that can help people. You can build things out of it, you can save the environment with hemp plastics, there are so many opportunities. 05:23

You don’t have to be doing paid media to be doing successful marketing on social 29:43

Instagram and Facebook are constantly trying to find ways of stopping people from talking about cannabis 27:11

Finding the cannabis consumer… in terms of media and marketing is actually quite complicated 34:20

Resources

Grab a ticket to Product Earth Expo 2021 from August 20-22: https://www.eventbrite.co.uk/e/product-earth-2021-tickets-120007378299?aff=ebdssbeac

Follow Matthew on LinkedIn: https://www.linkedin.com/in/matthew-clifton-5b171b14/

Follow Product Earth on LinkedIn: https://www.linkedin.com/company/20057712/

Follow Milk & Amber on LinkedIn: https://www.linkedin.com/company/milkandamber/

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

This week, we’re joined by Yoko Miyashita, CEO of Leafly - the world’s largest cannabis informational and educational resource.

In this episode, we explore how the Covid-19 pandemic forced innovation within the industry, and the findings of Leafly’s ‘Jobs 2021’ report which investigates the rapid acceleration of the cannabis job market in the USA.

→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e115

About Yoko

Yoko Miyashita was appointed CEO of Leafly in August 2020 after serving as the company’s General Counsel since 2019. Yoko has spent her career serving mission-driven companies navigating complex global regulatory environments in order to bring meaningful and compelling products to market. 

An expert in policy and advocacy, as General Counsel, she led Leafly’s position on key regulatory, compliance and government affairs issues. She has focused on progressing Leafly’s reputation as a trusted and authoritative cannabis resource and leveraged an understanding of current cannabis regulations, and opportunities for change, to help scale Leafly’s product and sales strategy.

Previously, Yoko spent 14 years at Getty Images, where she led the global legal team as SVP and general counsel. Prior to joining Getty Images, she practiced law with Perkins Coie LLP in Seattle. She holds a J.D. from the University of Washington School of Law and a B.A. from the University of California, Berkeley.

Quotables

Stigma for me [means] opportunity 05:40

This is our opportunity to re-educate the world about the potential of this plant, to make a huge difference 06:20

This industry is here to stay 16:05

Resources

Leafly’s Website: https://www.leafly.com/

Join Yoko on LinkedIn: https://www.linkedin.com/in/yoko-miyashita-4829161

Read Leafly’s Cannabis ‘Jobs Report 2021’: https://www.leafly.com/news/industry/cannabis-jobs-report

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

This week, we welcome back Deepak Anand (CEO) and Nick Pateras (Managing Director, Europe) of Materia - Cannabis and CBD supply and distribution company serving the growing cannabis and CBD markets in Europe.

In this episode, we investigate the different types of medical cannabis, the importance of Good Manufacturing Process (GMP), and the globalisation of the medical cannabis supply chain.

→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e114

About Deepak

Mr. Anand has a wealth of knowledge and experience in the global cannabis industry. He is a public speaker and is regularly engaged with Canadian and International media on all subjects related to the Cannabis industry. Mr. Anand holds a Master’s in Business Administration (MBA) and Management from Vancouver Island University. He is a recognized thought leader and brings15 years of leadership experience in the health, charitable/non-profit, and private sectors in Canada. Within the global cannabis sector, Mr. Anand has worked with senior government officials, politicians, policy makers, health professional organizations, clinical practitioners, educators, investors, patients as well as producers. He has also serves on the boards of various for and not for profit businesses and entities in the Cannabis sector. Currently, Mr. Anand serves as the Chief Executive Officer for Materia Ventures . Materia is a manufacturer and distributor of medical cannabis and CBD products across the burgeoning European market with offices and facilities in the UK, Germany, Malta as well as Canada.

About Nick

Nick Pateras is Managing Director, Europe at Materia, where he oversees the company’s operations across Germany, Malta and the UK. Materia is a manufacturer and distributor of medical cannabis and CBD products across the burgeoning European market. Previously, Nick served as Vice President, Strategy at Lift & Co., Canada’s leading cannabis education and insights platform. He is a regular speaker at cannabis conferences across North America and Europe and taught the Cannabis Business Fundamentals course at George Brown College in Toronto in 2018-19. Prior to his time in cannabis, Nick spent several years in the pharmaceutical sector with Johnson & Johnson Inc, managing various category-leading OTC and Health & Beauty businesses. 

Quotables

‘There’s always stigma associated with cannabis, anyone who thinks otherwise would probably be naive’ 01:58

‘What’s really exciting to us is seeing the establishment fna implementation of global supply chains’. 32:53

‘Legacy patients are comfortable with flower, they’re not looking to switch. But if you can get extracts to a place where they are covered by insurers, that would be an appealing proposition’ 36:40

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc 

This week’s guest on the Cannabis Conversation is Ken Clement, Executive Chairman of PRM Inc. - a vertically integrated Canadian phytopharmaceutical company.

In this show, we explore how manipulating environmental conditions can help to produce standardised plant compounds for medical use, and how this complex process differs from GMO.

→ View full show notes, summary, and access resources from this episode here: 

https://www.canverse.global/shownotes/e113

About Ken

Ken has been a successful serial entrepreneur building on 35 years of experience in multiple sectors. His experience in high level team sports along with numerous successful projects has influenced him to build strong teams reliant on passion, integrity and work ethic. His vision is unique in the medical cannabis sector with the concept of standardized production and dosage. Ken enjoys a strong rapport with regulatory organizations, scientists, thought leaders and numerous strategic partnerships worldwide. Ken has a proven track record, having built ABcann Global from an idea to a company valued in excess of $400 million.

Quotables

‘The future of medicine… is to get it as clean and as pure as possible’ 27:45

Resources

Follow Ken on LinkedIn: https://www.linkedin.com/in/ken-clement-150b998a/

Join PRM Inc. on Facebook https://www.facebook.com/plantsresearchmedicine

Follow PRM Inc. on Instagram: https://www.instagram.com/plantsresearchmedicine/

❇️ Get in touch at https://www.thecannabisconversation.co.uk

Connect with Nikita Cretu on LinkedIn:
https://www.linkedin.com/in/nikita-cretu-b24b83a8/
Connect with Thomas Gray on LinkedIn:
https://www.linkedin.com/in/thomas-c-s-gray/

🔋 The Cannabis Conversation is powered by Lumino - Europe's leading HR and Recruitment Agency specialising in building high performance teams for the legal cannabis industry. They work in three main verticals: Commercial, Medical and Plant-Facing. From HR advisory and executive search services to hiring support for full-time placements, consultants, or contract staff, Lumino has helped hundreds of companies of all sizes in the industry scale sustainably through the right people.

🌱 Need support finding the right talent to GROW your business? Book a call with our recruitment team at: https://calendly.com/d/zvg-y2d-tgc